Kang, M.-k.; Sohn, J.-H.; Cha, M.-J.; Kim, Y.H.; Hong, Y.; Im, H.-J.; Cho, S.-J.
One-Year Compliance After Calcitonin Gene-Related Peptide Monoclonal Antibody Therapy for Migraine Patients in a Real-World Setting: A Multicenter Cross-Sectional Study. J. Clin. Med. 2025, 14, 734.
https://doi.org/10.3390/jcm14030734
AMA Style
Kang M-k, Sohn J-H, Cha M-J, Kim YH, Hong Y, Im H-J, Cho S-J.
One-Year Compliance After Calcitonin Gene-Related Peptide Monoclonal Antibody Therapy for Migraine Patients in a Real-World Setting: A Multicenter Cross-Sectional Study. Journal of Clinical Medicine. 2025; 14(3):734.
https://doi.org/10.3390/jcm14030734
Chicago/Turabian Style
Kang, Mi-kyoung, Jong-Hee Sohn, Myoung-Jin Cha, Yoo Hwan Kim, Yooha Hong, Hee-Jin Im, and Soo-Jin Cho.
2025. "One-Year Compliance After Calcitonin Gene-Related Peptide Monoclonal Antibody Therapy for Migraine Patients in a Real-World Setting: A Multicenter Cross-Sectional Study" Journal of Clinical Medicine 14, no. 3: 734.
https://doi.org/10.3390/jcm14030734
APA Style
Kang, M.-k., Sohn, J.-H., Cha, M.-J., Kim, Y. H., Hong, Y., Im, H.-J., & Cho, S.-J.
(2025). One-Year Compliance After Calcitonin Gene-Related Peptide Monoclonal Antibody Therapy for Migraine Patients in a Real-World Setting: A Multicenter Cross-Sectional Study. Journal of Clinical Medicine, 14(3), 734.
https://doi.org/10.3390/jcm14030734